Drug Profile
Goat serum-derived polyclonal antibodies
Alternative Names: Aimspro; Caprine hyperimmune serum; Caprivax; Ceremben; Goat serum derived product; HICS; Hyperimmune caprine serum; Hyperimmune goat serum productLatest Information Update: 23 Jun 2015
Price :
$50
*
At a glance
- Originator Daval International
- Class Immunoglobulins; Polyclonal antibodies; Serum globulins
- Mechanism of Action Corticotropin-releasing hormone stimulants; Immunomodulators; Sodium channel modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Phase II Amyotrophic lateral sclerosis; Multiple sclerosis; Systemic scleroderma
Most Recent Events
- 23 Jun 2015 Aimspro® is still in active development for Amyotrophic lateral sclerosis in Australia and United Kingdom
- 23 Jun 2015 Aimspro® is still in active development for Multiple sclerosis and Systemic scleroderma in United Kingdom
- 25 Feb 2014 Daval International completes a phase II trial in Systemic scleroderma in United Kingdom (NCT00769028)